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Renal entactin (nidogen): Isolation, characterization and tissue distri-
bution. Entactin/nidogen (E/N) was isolated from bovine renal tubular
basement membrane. Apparent molecular weight, amino acid compo-
sition, and molecular configuration by electron microscopy rotary
shadowing were similar to that of nidogen from EHS mouse tumor. The
identity of bovine E/N was confirmed using a thrombin derived peptide,
the sequence of which corresponded to a region within mouse and
human E/N. Monoclonal and polyclonal anti-E/N antibodies were used
to determine the distribution of E/N in human kidney by immunofluo-
rescent and immunoelectron microscopy. E/N was present in all renal
basement membranes and was distributed through the full width of the
glomerular basement membrane (GBM) with accentuation along its
epithelial aspects. E/N distribution was similar to that of novel collagen
chain o3(IV) NC domain in the GBM. In the mesangium, E/N was
distributed mainly in the peripheral mesangial region that is bounded by
the GBM, while classical collagen chain ol(IV) NC as present diffusely
throughout the mesangium. In the developing nephron, EIN was
present in basement membranes of the ureteric bud, primitive vesicle
and S-form. In all instances, E/N co-localized with laminin B2 chain.
Prominent E/N detection within the mesangium was observed in
diseases where mesangial expansion was present. This process was also
seen in early diabetic nephropathy, but disappeared with disease
progression. However, all thickened diabetic renal basement mem-
branes showed an increase in E/N which was also present in Kimmel-
stiel-Wilson lesions. E/N was observed in the GBM "spikes" of
membranous glomerulonephritis and in epithelial crescents associated
with various disorders. The association between E/N, laminin and type
IV collagen chains observed in the normal kidney were maintained in
disorders with altered E/N distribution. We could not detect any
changes in the distribution of E/N in other acquired and hereditary
kidney diseases. These observations reflect the involvement of E/N in
the structure and disease alteration of renal basement membranes and
mesangial matrix.
Basement membranes are extracellular matrices which sup-
port vascular and epithelial cells, maintain tissue architecture,
and serve as barriers to macromolecules and migrating cells.
This molecular scaffold is composed of type IV collagen which
forms large cross-linked networks. Associated non-collagenous
proteins include laminin, proteoglycans, and entactin/nidogen
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(E/N) [1]. The latter glycoprotein was isolated from the mouse
EHS tumor and shown to consist of two globular domains
attached by a rod-like structure creating a dumbbell shaped
molecular [2, 3]. Nidogen is closely associated with laminin [4],
binds to type IV collagen [5], and modulates cell binding to
laminin [6]. The cDNA sequence for mouse nidogen has estab-
lished an identity with entactin, a glycoprotein isolated from
extracellular matrix of a mouse embryo cell line [7, 8]. Neither
nidogen nor entactin have been isolated and characterized from
an intact basement membrane.
Immunohistochemical studies have shown E/N to be part of
basement membranes of various organs. Its distribution in renal
extracellular matrices has been examined in rodents using
immunochemical techniques [2, 9—14].
We report the isolation and characterization of E/N from
bovine renal tubular basement membrane. Its distribution in
human kidney was studied by immunohistochemical techniques
using monoclonal and affinity-purified polyclonal antibodies.
We describe the relationship to laminin (B 1 and B2 chains), and
type IV collagen in normal human kidney, in various renal
disorders and during renal ontogeny.
Methods
Nidogen purification
Bovine kidney tubular basement membranes were prepared
as previously described [15]. Cortical tissue was dissected to
exclude medullary elements. Aliquots were suspended in a
solution containing ethylenediamine-tetracetic acid, epsilon
amino caproic acid, N-ethylmaleimide, and phenyl-methylsul-
fonyl fluoride protease inhibitors [15]. Following tissue disrup-
tion using a polytron homogenizer, the suspension was succes-
sively passed over metal sieves. Material retained on a #170
sieve was sonicated and centrifuged. The resultant pellet was
washed with 1.0 M NaC1 and distilled water, and then lyophi-
lized.
The crude basement membrane material was extracted over-
night with 6.0 M guanidine HC1, 50 m phosphate pH 7.4,
containing protease inhibitors, as above [15]. The extracts were
dialyzed extensively against 6.0 M urea 50 m phosphate pH
7.4 and subjected to ion exchange chromatography on DEAE-
cellulose in 6.0 M urea at 20°C. The column was eluted with a
0.0 to 0.8 M NaCI linear gradient. Column fractions containing
E/N were identified by SDS-PAGE, pooled, concentrated,
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dialyzed against 6.0 M urea 0.02 M Na acetate pH 4.8, and
passed over an S-Sepharose column at 20°C. Elution was
performed using a linear 0.0 to 0.4 M NaCl gradient, and
fractions containing EIN were pooled and dialyzed in guanidine
for further purification by Sephacryl S-300 gel ifitration. For
final purification, E/N obtained from gel filtration pools was
applied to a Mono Q column in 0.05 M Tris pH 7.4 and eluted in
a 0.0 to 0.5 M NaCI gradient.
Nidogen characterization and analysis
E/N in column fractions was identified by SDS-PAGE using 5
to 15% gradient slab gels [161. Molecular weight determination
was made using globular protein standards (Sigma Chemical
Co., St. Louis, Missouri, USA), including carbonic anhydrase,
egg albumin, bovine albumin, phosphorylase B, beta galactosi-
dase and myosin for calibration. EHS nidogen used as standard
was provided by Dr. Aris Charonis (University of Minnesota,
Rochester, Minnesota, USA). The presence of E/N in column
fractions and protein pools was verified by Western blotting [17]
using a semi-dry blot apparatus and rabbit antiserum to mouse
tumor EHS-derived nidogen (provided by R. Timpi, Max
Planck Institute for Biochemistry, Martinsried, Germany).
Amino acid analysis was performed on 25 to 50 jg of protein
hydrolyzed for 24 hours at 110°C in constant boiling HCI, and
analyzed on a Beckman 6300 amino acid analyzer using a
ninhydrin detection system. Intact E/N was incubated with
thrombin (0.1 U/mg protein, Sigma Chemical Co.) for 12 hours
at 37°C. Digestion fragments were purified by chromatography
on a TSK G 3000 SW Ultropac column in 4.0 M guanidine HC1
25 m phosphate pH 7.4. Selected peptides were then isolated
on a 0.4 x 15 cm Vydac C4 reverse-phase HPLC column.
Protein sequence determination of these peptides was done on
an Applied Biosystem Sequenator, using automated Edman
degradation. Amino acids were detected as PTH derivatives.
Amino acid analysis and sequence determination were per-
formed in the Microchemical Facility, Institute of Human
Genetics, University of Minnesota.
Rotary shadowing was performed on E/N samples in bicar-
bonate buffer as previously described [18]. Samples were shad-
owed under vacuum with a mixture of 95% platinum 5% carbon
in a Balzers apparatus and then examined with a Philips 300
transmission electron microscope operating at 60 KV (per-
formed by Drs. E. Tsilibary and A. Charonis, University of
Minnesota).
Immunologic methods
Polyclonal antibodies to E/N were made by immunizing
rabbits with purified bovine E/N. Affinity column purified
antibodies were prepared using E/N coupled to affinity matrix
discs (Nalge Company, Rochester, New York, USA). Bound
antibodies were eluted with 0.1 M glycine pH 2.5. To further
ensure antibody specificity, E/N was transferred from SDS-
PAGE gels to polyvinylidene difluoride (PVDF) membranes
(Millipore, Bedford, Massachusetts, USA) by semi-dry electro-
phoresis transfer. A strip containing E/N was cut from the
transfer membrane and reacted with antibodies previously
purified by affinity column chromatography as described above.
Antibody was then eluted from the strip using 0.1 51 glycine pH
2.5 and neutralized [19].
A monoclonal antibody to human E/N, Mab A9, was devel-
oped by immunizing mice with the collagenase resistant residue
of human GBM, using standard procedures [20]. Reactivity of
the monoclonal antibody was tested by Western blotting with
preparations of purified E/N and with 6.0 54 guanidine HC1 and
SDS extracts of human and bovine TBM. Monoclonal antibod-
ies MBM 102 and MBM 17 to human al(IV) and a3(IV) globular
domains of classical and novel type IV collagen chains, respec-
tively [21, 22], and 4E10 to laminin Bi chain (Dr. Eva Engvall)
and 2E8 to laminm B2 chain (Developmental Studies, Hybrid-
oma Bank, Johns Hopkins University) were also used [23].
Indirect immunofluorescent analysis was performed as pre-
viously described, using fluorescein labeled secondary antibod-
ies [23]. Cortical slices of human and bovine kidneys were snap
frozen in isopentane precooled in liquid nitrogen. Two micron
sections of frozen tissue were obtained and processed for
immunohistochemical analysis. Antibodies were tested on fro-
zen tissue sections that were processed in the conventional way
and also following tissue denaturation by incubation in acid-
urea [24]. Orientation and spatial distribution within basement
membranes was analyzed by high resolution phase-contrast
microscopy and epifluorescence. Dual antibody staining was
performed with appropriate controls as previously described
[22, 25] using in sequence mouse monoclonal anti-EIN, rho-
damine-conjugated goat antimouse IgG, rat anti-a 1(IV) NC,
and fluorescein-conjugated goat anti-rat IgG. Similarly, when
the tissue distribution of E/N and a3(IV) NC domain was
compared, tissue sections were first reacted with mouse mono-
clonal anti-a3(IV) NC followed by rhodamine conjugated goat
anti-mouse IgG, and then with affinity-purified rabbit anti-E/N
followed by fluorescein-conjugated goat anti-rabbit IgG. All
secondary antibodies were appropriately absorbed to avoid
cross reactive IgG binding. Control sections were stained with
absorbed secondary antibodies alone.
E/N distribution was determined in normal human and bovine
kidneys, during ontogeny using sections of human fetal kidney
of 16 to 22 weeks gestation, and in three to six patients with
each of the following disease states: IgA nephropathy, anaphy-
lactoid purpura nephritis, membranoproliferative glomerulone-
phritis type I and II, lupus nephritis, membranous glomer-
ulopathy, poststreptococcal glomerulonephritis, diabetic
nephropathy, familial (Alport) nephropathy, thin membrane
disease, autosomal-recessive polycystic kidney disease, mini-
mal change nephrotic syndrome, congenital nephrotic syn-
drome, and nephrotic syndrome with focal segmental sclerosis.
Immunoelectron microscopy
Small pieces of human and bovine kidneys were fixed in 2%
paraformaldehyde, 0.05% glutaraldehyde, 0.1% picric acid in
0.1 M Sorenson's phosphate buffer, or in periodate lysine
parafonnaldehyde fixative [26]. Samples were washed and
dehydrated in a graded ethanol series at successively lower
temperatures down to —35°C and infiltrated with Lowicryl
K4M. Ultrathin silver-to-gold interference contrast sections
were cut and mounted on formvar coated, 100-mesh nickel
grids. The grids were then floated on drops of phosphate buffer
saline containing 5% pre-immune serum of the animal in which
the secondary antibody was made for 10 minutes at 20°C. Grids
were then incubated overnight at 4°C with mouse monoclonal or
rabbit polyclonal anti-E/N antibodies; control staining of grids
with either normal mouse serum or normal rabbit serum was
routinely performed. This was followed by the application of
affinity-purified anti-mouse or anti-rabbit IgG coupled to 10 nm
colloidal gold particles for two hours at 20°C. The grids were
then washed with phosphate buffered saline 1% bovine serum
albumin and 0.05% Tween, and stained with uranyl acetate and
lead citrate and examined with a JEOL- 100CX electron micro-
scope at 60 KY.
Results
Bovine E/N purflcation
Guanidine extracts of bovine tubular basement membrane
were subjected to ion exchange chromatography on DEAE
cellulose in 6.0 M urea. By SDS-PAGE analysis, E/N was eluted
with few contaminating proteins in the ascending portion of the
first peak corresponding to 0.2 M NaCl of the salt gradient (Fig.
1A). These fractions were pooled and applied to a column of
S-Sepharose (Fig. 1B): samples from the major peak were
concentrated, dialyzed against 6.0 M guanidine, and further
resolved on a column of Sephacryl S-300 (not shown). Protein
from the main peak was applied to a Mono Q column in the final
purification step (Fig. 2). SDS-PAGE of the material eluted
from the Mono Q column showed a single band with an
apparent molecular weight of 168 kDa. This compares with a
molecular weight of 175 kDa observed for EHS nidogen in these
experiments. Figure 3 compares the mobilities of bovine tubular
basement membrane E/N (lane 1) with EHS nidogen (lane 6).
Bovine E/N reacted with the polyclonal antibody to EHS
mouse tumor nidogen (not shown), and with the monoclonal
and polyclonal anti-E/N antibodies by Western blotting (lanes 2
to 5).
Characterization of bovine nidogen
The amino acid composition of EIN derived from bovine
tubular basement membrane shows a similarity to that de-
scribed for EHS derived nidogen (Table 1). Minor differences
were observed in the content of glycine which was reduced in
concentration, while the amounts of valine and arginine were
increased compared to EHS nidogen. We were not successful in
obtaining an amino acid sequence of the intact form of purified
bovine E/N using automated Edman degradation.
The thrombin digest of the intact form of E/N generated three
major peaks on the TSK G 3000 SW HPLC column (Fig. 4A).
Upon reduction, the major peak (100 kDa molecular weight)
dissociated into two fragments which were separable by gel
filtration on TSK G 3000 SW column (Fig. 4B). The N-terminal
sequence of the smaller molecular weight fragment corresponds
to that described for a 22 kDa fragment generated through
thrombin digestion of EHS nidogen [271. Except for a substitu-
tion of proline by serine in position 6, the observed sequence is
identical to residues 1040 to 1051 in the amino acid sequence of
human nidogen deduced from placental cDNA (Fig. 5)1281.
Rotary shadowing of the intact bovine E/N disclosed ultrastruc-
tural conformation similar to that previously reported for this
molecule (Fig. 6).
Characterization of anti-E/N antibodies
Monoclonal anti-E/N antibody reacted with the intact form of
E/N and also recognized a 100 kDa E/N fragment (Fig. 3, lanes
2, 3). Minor reactivity with lower molecular weight fragments
Fraction #
Fig. 1. Fractionation of E/N by ion-exchange chromatography. Bo-
vine tubular basement membrane was extracted with guanidine and
dialyzed into urea-phosphate buffer and subjected to chromatography
on a column (2.5 x 15 cm) of DEAE-celiulose (A). Pooled fractions
indicated by the bar in panel A were further purified on a column (2.5 X
15 cm) of S-Sepharose (B). Columns were developed with a 0.0 to 0.8 M
(A) and 0.0 to 0.4 M (B) NaC1 gradient followed by a final batch elution
of S-Sepharose column with 1 M NaCI. Arrows indicate the start of the
salt gradient and the batch elution. The bar in panel B indicates pooled
fractions selected for further purification. Extraction and column buff-
ers are given in Methods.
was also seen. The antibody reacted in ELISA assays and
Western blots with E/N from bovine and human renal basement
membranes, and EHS tumor. The polyclonal anti-E/N antibody
showed reactivity similar to the monoclonal anti-E/N and also
recognized trace quantities of 70 to 80 kDa E/N degradation
products (Fig. 3, lanes 4, 5).
Tissue distribution of E/N
Affinity-purified rabbit anti-bovine E/N and monoclonal anti-
human E/N antibodies reacted similarly with both human and
bovine kidney, however, rabbit antibody to EHS tumor nidogen
reacted only with bovine kidney. E/N was present uniformly in
Bowman's capsule and the GBM. Diffuse staining of low
intensity was observed throughout the mesangium with accen-
tuation in the peripheral mesangial region which is bounded by
Katz et at: Renal entactin (nidogen) 645
E
U
-a
0
U)
.0
0-i
1
20 40 60 80
Sea S —
C p
646 Katz et a!: Renal entact in (nidogen)
E
5)u 0.1C(5
0(0
Fig. 2. Preparation of nidogen by Mono Q chromatography. Selected
pools from a Sephacryl S-300 gel filtration column (not shown) were
concentrated and applied to a Mono Q column in 0.05 M Tris, pH 7.4.
The arrow indicates the beginning of a 0.0 to 0.5 M NaCI gradient, and
pooled fractions shown by the bar contained the intact form of EIN used
in subsequent studies.
the reflection of the GBM (the waist area). GBM staining was
single linear and, by phase fluorescence microscopy showed
localization in the outer aspect of the GBM. Tubular basement
membrane and basement membranes of vessel walls, including
peritubular capillaries, were also stained (Fig. 7). Exposure of
tissue sections with acid urea reduced the staining intensity of
tubular basement membrane but did not alter that of the GBM.
Similar distribution was observed for laminin B2 chain in the
mesangium and other basement membranes while antibodies to
laminin B 1 chain only stained Bowman's capsule and weakly in
the mesangium. Using dual-labeled antibody staining, EIN was
observed to have a distribution similar to the putative a3(IV)
NC domain of type IV collagen along the outer aspect of the
GBM in a locus different from the subendothelial distribution of
the al(IV) NC of type IV classical collagen chains. In the
mesangium a3(IV) NC collagen chains were absent, whereas
E/N was present mainly in the region adjacent to the reflection
of the GBM, while al(IV) NC domain of classical type IV
collagen was distributed diffusely throughout the mesangium
(Fig. 8 A—F).
Immunoelectron microscopy confirmed these findings using
both polyclonal and monoclonal anti-E/N antibodies. E/N was
present in all basement membranes, in the mesangial matrix,
and in the GBM preferentially along its outer epithelial aspect
(Fig. 9).
We examined the distribution of E/N in the basement mem-
brane structures of the nephron during ontogenesis (Fig. 10).
Basement membranes of the ureteric bud, primitive vesicle,
S-form and glomerulus in the early capillary loop stage were
positive by indirect immunofluorescence. The distribution of
laminin B2 chain was identical to that of E/N. Antibody staining
for al(IV) NC was found in all the above structures, while the
novel chain a3(IV) NC appeared first in only the basement
Fig. 3. Electrophoresis and immunoblot analysis of E/N. Purified EIN
analyzed by SDS-PAGE and stained with silver is shown in lane 1.
Western blots of pure bovine E/N using monoclonal (lane 2) and
affinity-purified polyclonal anti-E/N antibodies (lane 4) demonstrate
binding of these antibodies to the purified protein. Western blots of
SDS-solubilized bovine tubular basement membrane with monoclonal
(lane 3) and polyclonal (lane 5) anti-E/N antibodies reveal a major band
corresponding in mobility to intact native E/N (lane 1) and a diffuse
band of approximately 100 kDa that is less intense. Trace quantities of
70 to 80 kDa material in SDS-soluble tubular basement membrane
representing E/N degradation products are identified with the poly-
clonal anti-E/N antibody (lane 5). Reactivity of the monoclonal anti-
body with EHS derived E/N (lane 6).
Table 1. Amino acid composition of bovine tubular basement
membrane entactin/nidogen
Amino acid
Species (residues /1000)
Bovine EHS nidogen
Aspartic acid 96 99
Threonine 65 66
Serine 76 85
Glutamic acid 113 113
Proline 73 67
Glycine 94 105
Alanine 62 60
Half-cystine 37 32
Valine 73 57
Methionine 8 5
Isoleucine 40 37
Leucine 66 66
Tyrosine 31 36
Phenylalanine 42 36
Histidine 30 33
Lysine 30 31
Arginine 64 55
Results are an average of 4 determinations. The composition of EHS
tumor nidogen is from Paulsson et a! [3].
membranes of the early glomerular capillary stage of nephron
development, as previously described [22].
Distribution of E/N in renal disorders
Prominent mesangial staining for E/N was seen in all diseases
in which mesangial expansion is a feature (systemic lupus
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Fig. 4. Purification of a thrombin-derived pep tide of E/N. E/N was
digested with thrombin and applied to a TSK 3000 gel filtration column
in 4.0 M guanidine (A). The major peak, indicated by the cross was
reduced with mercaptoethanol and the products were resolved by gel
filtration under the same conditions (B). The asterisk indicates the
peptide that was subjected to chemical sequencing.
erythematosus, IgA nephropathy, anaphylactoid nephritis and
membranoproliferative glomerulonephritis type I and II) (Fig.
11). A double contour E/N staining of the split GBM was seen
when mesangial interposition was present in type I membrano-
proliferative glomerulonephritis. Dense deposits present in type
II membranoproliferative glomerulonephritis did not react with
antibodies to E/N. Lacey staining with anti-E/N antibodies was
seen in epithelial crescents and in the sclerotic lesions of focal
segmental glomerular sclerosis. No staining for E/N was ob-
served in the subepithelial immune deposits of poststreptococ-
1040 1050
Bovine G I VTDSVRG NLY
Human
EHStumor P
Fig. 5. Amino-terminal sequence of a 22 kDa thrombin digestion
product of bovine tubular basement membrane E/N. Protein sequence
of E/N thrombin fragment (top line) is compared with homologous
regions of humans [28] and mouse EHS tumor nidogen [271. Complete
identity was found between the sequence of the peptide and the cDNA
derived sequence of human nidogen from amino acids 1040 to 1051
(numbering is according to the human sequence). One substitution
(ser/pro) in this region is seen compared to the EHS tumor sequence.
Fig. 7. Immunofluorescent microscopy using monoc/onal anti-EIN an-
tibody on normal human kidney. Reactivity is found in the glomerular
basement membrane, Bowman's capsule, tubular basement membrane,
and peritubular capillaries (arrow). In the mesangium E/N is detected
primarily within the waist (double arrows) region (x 410).
cal and membranous glomerulonephritis. In the latter EIN was
present in the basement membrane "spikes" adjacent to the
immune deposits along the epithelial aspect of the glomerular
basement membrane (Kim Y, manuscript submitted).
E/N distribution appeared normal in the renal basement
membranes of patients with Alport familial nephritis, thin
basement membrane disease, congenital and idiopathic ne-
phrotic syndrome, and in autosomal recessive polycystic kid-
ney disease.
In diabetic nephropathy, E/N was increased in all thickened
Katz el a!: Renal entactin (nidogen) 647
E
C)
0
.0
0.1
0.1
Fig. 6. Electron micrographs of purified bovine E/N following rotary
shadowing. Selected fields are shown displaying the dumbell shape
(arrows) characteristic of E/N (x 24,440).
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Fig. 8. Immunofluorescent microscopy of normal human kidney using dual label antibody staining. A—C. Monoclonal anti-E/N antibody (A),
phase microscopy (B), and monoclonal anti-al(IV) NC antibody (C). D—F. Polyclonal anti-E/N antibody (D), with phase microscopy (E), and
anti-a3(IV) NC antibody (F) (x 623).
basement membranes (Fig. 12). In the early stages of diabetic
mesangial expansion there was an increase in E/N staining of
matrix material including Kimmeisteil-Wilson nodules. With
progressive diabetic nephropathic change, E/N staining dimin-
ished in the mesangium; a similar pattern of al(IV) NC and
laminin B2 chain in the mesangium was found. Glomerular
basement membrane staining for E/N was increased in all stages
of diabetic nephropathy, and the same distribution and pattern
of staining was seen with antibodies to laminin B2 chain.
Increased glomerular basement membrane staining in all dis-
ease stages of diabetic nephropathy was also observed for the
a3(IV) NC domain of novel chain type IV collagen [29].
Discussion
We report the isolation and characterization of E/N from
bovine tubular basement membrane using methods similar to
those described for EHS tumor derived nidogen [3]. We found
that use of the S-Sepharose cation exchange column was more
effective than CM cellulose, and a final HPLC anion exchange
step (Mono Q column) was necessary to achieve satisfactory
purification of the intact form of E/N.
E/N derived from bovine renal tubular basement was found
to be similar to EHS derived nidogen in molecular weight,
pattern of endogenous proteolysis, amino acid composition,
and structure by rotary shadowing. The identity of the bovine
E/N thus purified was supported by the partial amino acid
sequence identity of a 22 kDa thrombin proteolytic product
compared with the same region of human nidogen [271. Our
results are thus in agreement with a previous report of cDNA
sequence similarity for human placental E/N and mouse tumor-
derived nidogen [301.
We observed that E/N was present in all human renal
basement membranes associated with vascular, tubular, and
glomerular elements. In the glomerulus, EIN was observed in
the GBM, mesangium and Bowman's capsule. EIN was present
through the full width of the GBM but appeared to be increased
along its epithelial aspect. Mesangial staining was light with
accentuation in the mesangial waist area (Table 2).
The distribution of E/N corresponded closely to that seen for
laminin B2 chain. A different staining pattern was observed for
laminin BI chain which was only detectable in Bowman's
capsule and minimally within the mesangium, and was not
found in the glomerular basement membrane [23]. In vitro
binding studies have shown EHS derived E/N to bind either to
the B! chain of laminin [4], or to both B! and B2 chains [31].
The above discrepancy could be attributed to the presence in
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Fig. 9. Immunoelectron
microscopy of the glomerulus
using the immunogold technique.
Immunoelectron microscopy of
the glomerulus using the
immunogold technique.
Monoclonal anti-E/N antibody
reactivity is localized to the
outer aspect of glomerular
basement membrane (A), and
diffusely throughout the
mesangium (B). Control staining
with normal mouse serum was
negative (x 46,500) (En
endothelium. Ep = visceral
epithelium).
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Fig. 10. Immunofluorescent microscopy of normal human fetal kidney.
Monoclonal anti-EIN antibody reactivity is seen in the basement
membranes of the ureteric bud (U) (A) and of the glomerular comma-
form (C) (B) which were identified by phase microscopy (not shown)
(x 410).
human kidney of laminin isoforms with binding properties
different than those of mouse laminin.
In the GBM, E/N distribution was similar to that of recently
discussed novel chains of type IV collagen [tentatively identi-
fied as s3(IV) and a4(IV)1 but differed from the distribution of
the al and c2 type IV collagen which has a subendothelial
localization. Although detected in different mesangial loci, E/N
and the classical type IV chains are found in the mesangium,
whereas the novel type IV chains are absent from this region
(Table 2).
During renal ontogeny E/N distribution is similar to laminin
B2 chain, but different from laminin B I chain (not shown). Like
EIN, classical type IV collagen chains are present early in
ontogeny while the novel chains appear in the primitive glomer-
uli after vascular migration into the S-form [22]. E/N thus seems
to be an active participant in the complex process of ontogenic
development of the fused glomerular basement membrane. In
the immunohistochemical studies of fetal, normal, and diseased
human kidneys, the same staining patterns for E/N were
observed using the monoclonal and rabbit anti-E/N antibodies.
E/N staining was increased in all diseases with mesangial
expansion. When mesangial interposition is present in type I
Fig. 11. Immunofluorescent microscopy in type I membranoprolifera-
tive glomerulonephritis using monoclonal anti-E/N antibody. Increased
staining reactivity associated with mesangial proliferation (A). Further
mesangial expansion with glomerular lobulation, and lacey staining of
an epithelial crescent (EC) identified by phase microscopy (not shown)
within Bowman's space (BS) (B) (x 410).
membranoproliferative glomerulonephritis, antibodies to EIN
stain the glomerular basement membrane in a double linear
pattern reflecting the presence of EIN in the lamina densa and in
the interposed mesangial matrix. In membranous nephropathy
FIN was present in the "spikes" surrounding the subepithelial
immune complexes, likely reflecting increased synthesis by
visceral epithelial cells, and similar to studies using antibodies
to laminin and the novel collagen chains [Kim Y, et al,
manuscript in preparation].
In diabetic kidney, E/N and laminin B2 chain were increased
in all thickened basement membranes and remained altered in
this fashion with progression of the disease. E/Nand laminin B2
chain were present throughout the expanded mesangial matrix
in early diabetic glomerulopathy but diminished in advanced
nephropathy, whereas these components persisted in the GBM
in advanced diabetic nephropathy similar to that observed for
the novel chains of type IV collagen [291.
Previous reports have shown circulating anti-E/N antibodies
in sera of patients with acute poststreptococcal glomerulone-
phritis [32], Goodpasture syndrome [33], and in experimental
membranous glomerulopathy [34], suggesting a role for E/N in
r-r f
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Table 2. Distribution of entactin/nidogen compared to other
extracellular matrix components in normal human kidney
by immunofluorescence
Location
Matrix componentsa
E/N LM s1(IV) a3(IV)
Glomerulus
Mesangium + + + —
Capillary subendothelium — — + —
Glomerular basement membrane + + — +
Tubule
Tubular basement membrane + + + +
Vessels
Arterioles + + + —
Capillary bed + + + —
a Matrix components are present (+) or absent (—). Abbreviations
are: E/N, entactin/nidogen; LM, laminin B2 chain; al(IV), NC domain
type l(IV) collagen chain; a3(IV), NC domain type 3(IV) collagen
chain.
Fig. 12. Immunofluorescent microscopy in diabetic nephropathy using
dual-label antibody staining of the same glomerulus. Polyclonal anti-
E/N antibody (A), phase microscopy (B), and anti-al(IV) NC antibody
(C). Diffuse mesangial staining for E/N and classic type IV collagen
chains is evident (x 576).
the pathogenesis of these immune complex disorders. Reactiv-
ity of the dense deposits seen in type II membranoproliferative
glomerulonephritis [35] with wheat germ agglutinin could also
suggest the presence of E/N since the latter reacts in vitro with
wheat germ agglutinin [36]. Our findings do not support the
presence of E/N either in the immune complexes of patients
with acute poststreptococcal and membranous glomerulopathy,
or in dense deposit material.
Since the observations of E/N distribution in various renal
diseases are derived from limited numbers of patients with each
disorder in this study, the following conclusions are tentatively
proposed, pending more extensive study. The presence of E/N
in all renal basement membranes and mesangial matrix in the
mature kidney and all stages of renal ontogeny is an indication
of its importance to renal structure. Furthermore, E/N distri-
bution in basement membranes is not altered in disorders in
which morphologic alterations of basement membrane structure
has been observed (cystic kidney disease, Alport's familial
nephritis, thin membrane disease) or when altered filtration
permeability is present (idiopathic and congenital nephrotic
syndrome) [37—39]. E/N co-localizes with laminin B2 chain
while its relationship to type IV collagen varies from the
mesangium (classical type IV) to glomerular basement mem-
brane (novel type IV) collagen chains. These relationships are
maintained in disease states where changes of mesangial prolif-
eration are associated with increased E/Ndeposition along with
laminin B2 and classic type IV collagen chains. However, GBM
thickening is associated with increased deposition of E/N,
laminin B2 and novel type IV collagen chains.
We propose that these changes reflect heightened synthetic
capacity of glomerular mesangial cells in glomerular prolifera-
tive disorders, and glomerular epithelial cells in diabetic and
membranous nephropathy, resulting in increased deposition of
E/N in the mesangium and the glomerular basement membrane,
respectively. Additional studies are needed to define synthesis
of E/N by glomerular cell types and the factors which are
responsible for their control.
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